Bill would clarify state, FDA roles for drug compounding

04/30/2013 | InfectionControlToday.com

A draft bill from the Senate Health, Education, Labor and Pensions Committee would define the respective roles of state authorities and the FDA in the oversight of pharmaceutical compounding companies. Under the proposed legislation, traditional drug compounding to fill patient prescriptions would continue to be the responsibility of states. The FDA, however, would oversee compounding manufacturers that make sterile products without prescriptions and transport them across state lines.

View Full Article in:

InfectionControlToday.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA